Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for AVDL

Stock NameAvadel Pharmaceuticals PLC
TickerAVDL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05337M1045

Show aggregate AVDL holdings

News associated with AVDL

Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $36.00
Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) had its price objective hoisted by HC Wainwright from $24.00 to $36.00 in a research report released on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Avadel Pharmaceuticals’ Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.19 […] - 2025-09-08 02:04:58
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members. - 2025-08-28 13:50:00
Avadel Pharmaceuticals (NASDAQ:AVDL) Upgraded to Strong-Buy at Wall Street Zen
Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday. Several other equities research analysts have also recently issued reports on AVDL. Needham & Company LLC reaffirmed a “buy” rating and set a $19.00 target […] - 2025-08-11 04:32:58
Avadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from HC Wainwright
Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report)‘s stock had its “buy” rating reiterated by HC Wainwright in a research note issued on Friday, Marketbeat.com reports. They presently have a $24.00 target price on the stock, up from their previous target price of $22.00. HC Wainwright’s target price indicates a potential upside of 88.24% from the […] - 2025-08-11 03:08:46
Modera Wealth Management LLC Has $4.38 Million Position in Avadel Pharmaceuticals PLC. (NASDAQ:AVDL)
Modera Wealth Management LLC reduced its stake in Avadel Pharmaceuticals PLC. (NASDAQ:AVDL – Free Report) by 28.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 558,977 shares of the company’s stock after selling 223,590 shares during the period. Modera Wealth […] - 2025-07-31 04:32:49
Teacher Retirement System of Texas Reduces Position in Avadel Pharmaceuticals PLC. (NASDAQ:AVDL)
Teacher Retirement System of Texas trimmed its holdings in shares of Avadel Pharmaceuticals PLC. (NASDAQ:AVDL – Free Report) by 9.3% during the first quarter, Holdings Channel reports. The fund owned 23,342 shares of the company’s stock after selling 2,396 shares during the quarter. Teacher Retirement System of Texas’ holdings in Avadel Pharmaceuticals were worth $183,000 […] - 2025-07-21 04:49:03
Analysts Set Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Target Price at $18.17
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have updated their coverage on the […] - 2025-07-18 02:37:01
Avadel Pharmaceuticals (NASDAQ:AVDL) Share Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $8.73 and traded as high as $8.95. Avadel Pharmaceuticals shares last traded at $8.93, with a volume of 361,574 shares. Analyst Upgrades and Downgrades Separately, Needham […] - 2025-07-04 05:14:59
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Average Recommendation of “Buy” from Brokerages
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL – Get Free Report) has been assigned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have issued a report on the […] - 2025-06-20 03:08:49
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $19.43 Average Price Target from Analysts
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average rating of “Buy” from the seven research firms that are presently covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have issued ratings on the stock […] - 2025-05-29 02:43:07
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Acquired by Deutsche Bank AG
Deutsche Bank AG lifted its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 6.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 508,696 shares of the company’s stock after acquiring an additional 32,227 shares during the quarter. Deutsche Bank AG’s holdings in Avadel Pharmaceuticals were worth $5,346,000 at the end […] - 2025-05-19 05:07:01
Voya Investment Management LLC Has $296,000 Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Voya Investment Management LLC lessened its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 6.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,151 shares of the company’s stock after selling 2,085 shares during the period. Voya […] - 2025-05-12 05:32:50
10,750 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC purchased a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 10,750 shares of the company’s stock, valued at approximately $113,000. A number of other large investors also recently added to or reduced […] - 2025-05-12 04:58:53
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up on Earnings Beat
Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) gapped up prior to trading on Wednesday following a stronger than expected earnings report. The stock had previously closed at $8.64, but opened at $9.75. Avadel Pharmaceuticals shares last traded at $9.10, with a volume of 577,848 shares trading hands. The company reported ($0.05) EPS […] - 2025-05-09 02:20:47
Envestnet Asset Management Inc. Decreases Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Envestnet Asset Management Inc. trimmed its stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 54.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,825 shares of the company’s stock after selling 32,618 shares during the quarter. Envestnet […] - 2025-05-07 04:36:50
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Stock Position Raised by MetLife Investment Management LLC
MetLife Investment Management LLC lifted its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 6.1% during the fourth quarter, Holdings Channel reports. The firm owned 57,068 shares of the company’s stock after purchasing an additional 3,271 shares during the quarter. MetLife Investment Management LLC’s holdings in Avadel Pharmaceuticals were worth $600,000 […] - 2025-05-05 05:30:47
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Acquired by Renaissance Technologies LLC
Renaissance Technologies LLC raised its position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 1,703.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 387,800 shares of the company’s stock after buying an additional 366,300 shares during the quarter. Renaissance Technologies […] - 2025-04-22 05:45:01
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $19.88 Average Target Price from Brokerages
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average rating of “Buy” from the eight ratings firms that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their coverage on the […] - 2025-04-09 02:05:03
Teacher Retirement System of Texas Boosts Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Teacher Retirement System of Texas raised its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 33.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,738 shares of the company’s stock after purchasing an additional 6,451 shares during the […] - 2025-04-02 04:44:48
Intech Investment Management LLC Raises Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Intech Investment Management LLC lifted its stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 259.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,758 shares of the company’s stock after purchasing an additional 42,418 shares during the period. Intech Investment […] - 2025-03-25 06:29:10
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Recommendation of “Buy” from Analysts
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been given an average rating of “Buy” by the eight ratings firms that are covering the company, MarketBeat reports. Eight research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in the […] - 2025-03-12 04:24:54
Sanctuary Advisors LLC Buys New Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Sanctuary Advisors LLC bought a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 13,291 shares of the company’s stock, valued at approximately $140,000. Several other large investors have also modified their holdings of the business. Creative Planning raised its holdings in shares of […] - 2025-03-06 09:52:51
Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Oppenheimer & Co. Inc. boosted its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) by 102.6% during the 4th quarter, Holdings Channel.com reports. The firm owned 67,068 shares of the company’s stock after purchasing an additional 33,963 shares during the period. Oppenheimer & Co. Inc.’s holdings in Avadel Pharmaceuticals were worth $705,000 as of […] - 2025-03-06 09:11:30
Needham & Company LLC Reaffirms “Buy” Rating for Avadel Pharmaceuticals (NASDAQ:AVDL)
Needham & Company LLC reiterated their buy rating on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) in a research report released on Monday,Benzinga reports. The brokerage currently has a $19.00 price objective on the stock. A number of other brokerages also recently issued reports on AVDL. UBS Group lowered their price objective on Avadel […] - 2025-03-04 04:50:48
Nations Financial Group Inc. IA ADV Purchases Shares of 15,550 Avadel Pharmaceuticals plc (NASDAQ:AVDL)
Nations Financial Group Inc. IA ADV acquired a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 15,550 shares of the company’s stock, valued at approximately $163,000. A number of other institutional investors and […] - 2025-02-19 07:21:08
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $19.88 Consensus PT from Analysts
Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have issued a […] - 2025-02-18 04:13:05
Avadel Pharmaceuticals (NASDAQ:AVDL) Coverage Initiated at Deutsche Bank Aktiengesellschaft
Analysts at Deutsche Bank Aktiengesellschaft assumed coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) in a research report issued on Tuesday, Marketbeat.com reports. The firm set a “buy” rating and a $12.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 34.68% from the company’s […] - 2025-02-13 06:22:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) AVDL holdings

DateNumber of AVDL Shares HeldBase Market Value of AVDL SharesLocal Market Value of AVDL SharesChange in AVDL Shares HeldChange in AVDL Base ValueCurrent Price per AVDL Share HeldPrevious Price per AVDL Share Held
2025-11-11 (Tuesday)62,352USD 1,174,088USD 1,174,088
2025-11-10 (Monday)62,352AVDL holding increased by 160USD 1,165,982AVDL holding increased by 3614USD 1,165,982160USD 3,614 USD 18.7 USD 18.69
2025-11-07 (Friday)62,192USD 1,162,368AVDL holding decreased by -1244USD 1,162,3680USD -1,244 USD 18.69 USD 18.71
2025-11-06 (Thursday)62,192AVDL holding increased by 160USD 1,163,612AVDL holding decreased by -12515USD 1,163,612160USD -12,515 USD 18.71 USD 18.96
2025-11-05 (Wednesday)62,032USD 1,176,127AVDL holding increased by 3722USD 1,176,1270USD 3,722 USD 18.96 USD 18.9
2025-11-04 (Tuesday)62,032AVDL holding increased by 160USD 1,172,405AVDL holding increased by 1787USD 1,172,405160USD 1,787 USD 18.9 USD 18.92
2025-11-03 (Monday)61,872USD 1,170,618AVDL holding increased by 1856USD 1,170,6180USD 1,856 USD 18.92 USD 18.89
2025-10-31 (Friday)61,872USD 1,168,762AVDL holding increased by 3712USD 1,168,7620USD 3,712 USD 18.89 USD 18.83
2025-10-30 (Thursday)61,872AVDL holding increased by 805USD 1,165,050AVDL holding increased by 10884USD 1,165,050805USD 10,884 USD 18.83 USD 18.9
2025-10-29 (Wednesday)61,067AVDL holding increased by 322USD 1,154,166AVDL holding increased by 24916USD 1,154,166322USD 24,916 USD 18.9 USD 18.59
2025-10-28 (Tuesday)60,745USD 1,129,250AVDL holding increased by 1823USD 1,129,2500USD 1,823 USD 18.59 USD 18.56
2025-10-27 (Monday)60,745USD 1,127,427USD 1,127,4270USD 0 USD 18.56 USD 18.56
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AVDL by Blackrock for IE00BYXG2H39

Show aggregate share trades of AVDL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY16018.81018.680 18.693USD 2,991 10.79
2025-11-06BUY16018.98018.710 18.737USD 2,998 10.71
2025-11-04BUY16018.95518.785 18.802USD 3,008 10.62
2025-10-30BUY80518.90018.720 18.738USD 15,084 10.49
2025-10-29BUY32218.90018.950 18.945USD 6,100 10.45
2025-10-22SELL-64018.53018.650 18.638USD -11,928 10.23 Loss of -5,383 on sale
2025-10-20BUY32015.80015.820 15.818USD 5,062 10.16
2025-10-17BUY79915.22015.250 15.247USD 12,182 10.13
2025-10-15BUY1,27215.16015.170 15.169USD 19,295 10.10
2025-10-03BUY1,12715.01015.580 15.523USD 17,494 10.05
2025-10-02BUY16114.94015.210 15.183USD 2,444 10.02
2025-09-30BUY32215.27015.530 15.504USD 4,992 9.96
2025-09-26BUY32215.34015.560 15.538USD 5,003 9.90
2025-09-25BUY32215.33015.620 15.591USD 5,020 9.87
2025-09-24SELL-3,53315.59015.890 15.860USD -56,033 9.84 Loss of -21,280 on sale
2025-09-18BUY17116.23016.280 16.275USD 2,783 9.80
2025-09-17BUY51615.66015.990 15.957USD 8,234 9.76
2025-08-20SELL-68414.25014.330 14.322USD -9,796 9.64 Loss of -3,200 on sale
2025-07-30BUY68410.70011.030 10.997USD 7,522 9.53
2025-07-17SELL-34210.84011.030 11.011USD -3,766 9.45 Loss of -535 on sale
2025-07-11SELL-1,3769.6109.820 9.799USD -13,483 9.43 Loss of -511 on sale
2025-07-07BUY5168.8909.000 8.989USD 4,638 9.43
2025-07-02BUY9,4608.8108.940 8.927USD 84,449 9.44
2025-06-20BUY2,8259.1809.480 9.450USD 26,696 9.44
2025-06-11BUY3269.89010.350 10.304USD 3,359 9.44
2025-06-10BUY32610.23010.500 10.473USD 3,414 9.43
2025-06-04SELL-1639.3109.560 9.535USD -1,554 9.43 Loss of -18 on sale
2025-04-23BUY1638.3108.490 8.472USD 1,381 9.55
2025-04-10SELL-1,3047.1307.310 7.292USD -9,509 9.72 Profit of 3,166 on sale
2025-04-08SELL-1636.5907.100 7.049USD -1,149 9.78 Profit of 446 on sale
2025-04-07SELL-1636.6906.990 6.960USD -1,134 9.82 Profit of 466 on sale
2025-04-04SELL-8206.8007.070 7.043USD -5,775 9.86 Profit of 2,307 on sale
2025-04-01BUY6727.5107.750 7.726USD 5,192 9.91
2025-03-31SELL-4927.8308.050 8.028USD -3,950 9.94 Profit of 940 on sale
2025-03-21BUY2,8978.5708.670 8.660USD 25,088 10.07
2025-03-14SELL-2,4968.3308.490 8.474USD -21,151 10.17 Profit of 4,235 on sale
2025-03-07SELL-3107.9107.940 7.937USD -2,460 10.34 Profit of 744 on sale
2025-03-04SELL-1567.6407.860 7.838USD -1,223 10.46 Profit of 409 on sale
2025-02-25BUY3128.1008.390 8.361USD 2,609 10.68
2025-02-19SELL-1548.4108.610 8.590USD -1,323 10.85 Profit of 349 on sale
2025-02-13BUY4598.9909.100 9.089USD 4,172 11.03
2025-02-12BUY1548.9109.340 9.297USD 1,432 11.07
2025-02-11BUY6129.0009.190 9.171USD 5,613 11.11
2024-12-30SELL-5,18910.50010.670 10.653USD -55,278 12.37 Profit of 8,893 on sale
2024-11-18SELL-2,49010.72011.010 10.981USD -27,343 14.08 Profit of 7,710 on sale
2024-11-08SELL-16615.94016.120 16.102USD -2,673 14.01 Loss of -347 on sale
2024-10-21SELL-16713.42013.700 13.672USD -2,283 0.00 Loss of -2,283 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AVDL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19244,8351,750498,36649.1%
2025-09-18222,4120650,00334.2%
2025-09-17241,802600614,48639.4%
2025-09-16167,633100429,52739.0%
2025-09-15329,339808658,04950.0%
2025-09-12186,7350389,56847.9%
2025-09-11240,9381,759693,60034.7%
2025-09-10288,9541,000778,39437.1%
2025-09-09199,501265457,37643.6%
2025-09-08178,243762570,08731.3%
2025-09-05148,5347,750978,67215.2%
2025-09-04203,3463841,94724.2%
2025-09-03252,682200813,47331.1%
2025-09-02115,6130546,33421.2%
2025-08-29166,3532,820826,07520.1%
2025-08-2881,6790299,16327.3%
2025-08-27148,0760445,50033.2%
2025-08-26202,923625470,95743.1%
2025-08-25269,7791,375699,45038.6%
2025-08-22167,3589,700524,32531.9%
2025-08-21258,6547,804728,80335.5%
2025-08-20272,9288,000458,88859.5%
2025-08-19118,146777235,47750.2%
2025-08-18132,0642,319345,35938.2%
2025-08-1591,12910,670387,53623.5%
2025-08-14106,5871373,79428.5%
2025-08-13255,921200592,68843.2%
2025-08-12233,2756,400491,69547.4%
2025-08-11189,600500605,15331.3%
2025-08-08278,0099,223559,05449.7%
2025-08-07531,70110,1631,799,50329.5%
2025-08-06195,1590596,07232.7%
2025-08-05101,4260253,82140.0%
2025-08-04122,3120230,44553.1%
2025-08-01174,6910304,14957.4%
2025-07-3182,5200209,73439.3%
2025-07-30135,3280258,47452.4%
2025-07-2998,2250175,89155.8%
2025-07-28145,9250294,81949.5%
2025-07-25228,1120343,53866.4%
2025-07-24143,4622322,06944.5%
2025-07-23188,1693,944513,28936.7%
2025-07-22188,228978504,86837.3%
2025-07-21355,2290580,84961.2%
2025-07-18243,9130425,12157.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.